GhazawiFMNetchiporoukERahmeEet al. Distribution and clustering of cutaneous T-cell lymphoma (CTCL) cases in Canada during 1992 to 2010. J Cutan Med Surg. 2018;22(2):154-165.
2.
GhazawiFMNetchiporoukERahmeEet al. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy. Cancer. 2017;123:3550-3567.
3.
LitvinovIVTetzlaffMTRahmeEet al. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer. 2015;121:1993-2003.
4.
LitvinovIVTetzlaffMTRahmeEet al. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Med. 2015;4:1440-1447.
5.
LitvinovIVShtreisAKobayashiKet al. Investigating potential exogenous tumor initiating and promoting factors for cutaneous T-cell lymphomas (CTCL), a rare skin malignancy. Oncoimmunology. 2016;5:e1175799.
6.
MoreauJFBuchanichJMGeskinJZAkilovOEGeskinLJ. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area. Dermatol Online J. 2014;20(7). pii: 13030/qt4nw7592w.
7.
TuypEBurgoyneAAitchisonTMacKieR. A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol. 1987;123:196-200.
8.
KirschIRWatanabeRO’MalleyJTet al. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Translational Med. 2015;7:308ra158.
